Market Place
Sourcing Support
Shilpa Pharma Names Dr. Vellaian Karuppiah COO For Formulations
24 Apr 2026 //
INDPHARMAPOST
Shilpa Medicare Seeks US Approval for 5-HT3 Antagonist in CINV
12 Jan 2026 //
PHARMIWEB
Shilpa Medicare Aims For US Approval Of Chemo Nausea Drug
09 Jan 2026 //
INDPHARMAPOST
Shilpa Pharma Lifesciences Earns Ecovadis Gold For Sustainability
11 Nov 2025 //
PR NEWSWIRE
Shilpa Medicare allots 9, 77, 90,908 bonus equity shares
07 Oct 2025 //
BUSINESS STD
Shilpa Medicare’s NorUDCA First Approved NAFLD Therapy
14 Aug 2025 //
FIERCE PHARMA
Shilpa Medicare`s Dabaspet UnitVI Get GMP Certification from SFDA
11 Jul 2025 //
INDPHARMAPOST
Shilpa Pharma Lifesciences Unit-1 inspected by ANVISA
06 Jul 2025 //
INDPHARMAPOST
Shilpa Medicare gets CDSCO nod for UDCA tablets
16 Apr 2025 //
EXPRESSPHARMA
Amneal Launches Boruzu for Multiple Myeloma & Lymphoma
01 Apr 2025 //
BUSINESSWIRE
Shilpa Medicare Launches Full Service Hybrid CDMO
11 Mar 2025 //
CONTRACTPHARMA
Shilpa Medicare’s Unit Receives GMP Certificate from EMA, Austria
22 Dec 2024 //
INDPHARMAPOST
Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
28 Nov 2024 //
INDPHARMAPOST
Shilpa Medicare as Subsidiary Gets EU Nod for Blood Pressure Drug
19 Nov 2024 //
CNBCTV
Shilpa Medicare Q2 FY25 consolidated PAT up 1,008% at Rs. 18 Cr
15 Nov 2024 //
INDPHARMAPOST
Amneal and Shilpa Announce FDA Approval Of BORUZU, Ready-to-Use
05 Sep 2024 //
BUSINESSWIRE
Shilpa Medicare Completes Phase 1 Trial For Recombinant Albumin
28 Aug 2024 //
PR NEWSWIRE
Shilpa Medicare Completes Phase-3 Trial For Nonalcoholic Fatty Liver Disease
26 Aug 2024 //
ECONOMICTIMES
Shilpa`s CDMO customer placed binding purchase order
08 Jul 2024 //
INDIAPHARMAPOST
Shilpa Medicare launches Pemetrexed injection
19 Apr 2024 //
INDINPHARMAPOST
Shilpa Medicare gets Europe approval for Varenicline Tablets, 0.5mg and 1mg
26 Feb 2024 //
INDIAN PHARMA POST
Shilpa Medicare directed to to pay damage to Celltrion
25 Jan 2024 //
INDIAN PHARMA POST
Shilpa Medicare shares up 2% on acquiring US-based Pilnova Pharma
03 Nov 2023 //
MONEY CONTROL
Shilpa Medicare launches `Oraal’ for treatment of oral mucositis
13 Oct 2023 //
INDIAN PHARMA POST
Shilpa Medicare receives MHRA approval for mouth-dissolving strips
03 Sep 2023 //
INDIAN PHARMA POST
Shilpa Medicare launches Lenvatinib Capsules in India under the brand Lenshil
30 Jun 2023 //
INDIAN PHARMA POST
Shilpa Medicare introduces cancer drug Capecitabine 1000 MG dispersible tablet
19 Dec 2022 //
INDIANPHARMAPOST
Shilpa Medicare introduces cancer drug Capecitabine 1000 MG dispersible tablet
19 Dec 2022 //
INDIANPHARMAPOST
Briefs: Piramal Enterprises and Shilpa Medicare
02 Dec 2022 //
INDIAPHARMAPOST
Shilpa Medicare Hyderabad facility receives US FDA clearance
23 Sep 2022 //
INDIANPHARMAPOST
Shilpa Medicare arm gets NoC to conduct clinical studies forAflibercept
26 Apr 2022 //
ECONOMICTIMES
Shilpa Medicare to make Cadila`s Covid-19 vaccine
23 Sep 2021 //
DECCANHERALD
Steriline Supplies Shilpa Medicare with Pilot Line for Injectable Oncology Drugs
20 Jul 2021 //
CONTRACT PHARMA
Shilpa Medicare Joins Dr. Reddy`s to Manufacture 5 Crore Doses of Sputnik V
17 May 2021 //
NEWS18
Shilpa Pharma sues Novartis Pharmaceutical Corporation for patent infringement
28 Apr 2021 //
THEHINDUBUSINESSLINE
India`s Shilpa Medicare can make 100-200 million doses of COVID-19 shot,
06 Apr 2021 //
INDIATIMES
Shilpa Medicare gets tentative American health regulator nod for Apremilast tab
05 Mar 2021 //
ECONOMIC TIMES
USFDA issues warning to Shilpa Medicare for CGMP violations at Telangana plant
30 Oct 2020 //
ECONOMICTIMES
FDA Reveals Details Of Shilpa’s Violations
30 Oct 2020 //
PHARMAINTELLIGENCE.INFORMA
Shilpa Medicare gains 5% on launch of generic drug for kidney cancer
29 Jun 2020 //
MONEYCONTROL
Shilpa Medicare launches Ibrushil for leukaemia treatment
28 May 2020 //
PHARMABIZ
Shilpa Medicare launches branded generic anticancer drug Dasatinib
23 Apr 2020 //
PHARMABIZ
Shilpa Medicare`s subsidiary gets UK regulator nod for anti-cancer drug
06 Apr 2020 //
MONEYCONTROL
Shilpa Medicare hits fresh 52-week high; stock zooms 89% in a month
24 Feb 2020 //
BUSINESS-STANDTARD
Shilpa Medicare Launches Breakthrough Therapy Lenvatinib Mesylate
03 Feb 2020 //
BUSINESS
Shilpa Medicare receives EIR from US FDA for Jadcherla unit
25 Oct 2019 //
PHARMABIZ
Shilpa Medicare gets USFDA nod for cancer drug
17 May 2019 //
ECONOMIC TIMES
Shilpa Medicare gets US FDA approval azacitidine injection
04 Oct 2016 //
PHARMABIZ
Shilpa Medicare surges on USFDA nod for Jadcherla unit
26 Jul 2016 //
BUSINESS STANDARD
Shilpa Medicare rallies on getting GMP compliance certificate
12 Apr 2016 //
BUSINESS STANDARD
Telangana regulator inspects 12 units of major pharma firms for quality issues
19 Feb 2016 //
FINANCIAL EXPRESS
Shilpa Medicare gains after block deal
15 Feb 2016 //
BUSINESS STANDARDS
Shilpa Medicare rises on receiving USFDA compliance letter for Karnataka plant
10 Feb 2016 //
BUSINESS STANDARD
Gland Chemicals Receives Written Confirmation of Export of 3 APIs to EU
20 Jan 2016 //
TWOFOUR INSIGHT
